Nicolau Syndrome Following Intralesional Sclerotherapy: A Dreaded Complication of a Simple Office Procedure

N. Deshmukh, V. Belgaumkar, R. Chavan, N. Bhatt
{"title":"Nicolau Syndrome Following Intralesional Sclerotherapy: A Dreaded Complication of a Simple Office Procedure","authors":"N. Deshmukh, V. Belgaumkar, R. Chavan, N. Bhatt","doi":"10.5812/JSSC.107198","DOIUrl":null,"url":null,"abstract":"Introduction: Nicolau syndrome is an iatrogenic dreaded adverse skin reaction leading to ischemic necrosis of skin and underlying tissue after parenteral drug injection. The etiopathogenesis is poorly understood. However, inflammation, reflex vasospasm, and thrombo-embolic occlusion of blood vessels, including arterioles and arteries, are suggested as the cause of ischemia. Case Presentation: We report a 12-year-old girl who developed Nicolau syndrome after a simple office procedure of intralesional sclera therapy with sodium tetradecyl sulfate for a apyogenic granuloma on her right index finger. Three days later, she reported complaints of excruciatingly painful swelling with bluish discoloration of the right hand involving the palm, entire index, middle, and ring fingers, and distal part of the little finger. Nicolau syndrome was documented after intramuscular injections of drugs. Nevertheless, there are very few reports of Nicolau syndrome following post intralesional sclerotherapy. Conclusions: Sclerotherapy is a simple office procedure routinely performed by health care professionals (e.g., dermatologists and surgeons), and awareness about its dreaded entity is key. Stringent precautions and prompt management can prevent unfavorable complications. Additionally, prudent patient selection and detailed counseling with explicit informed consent regarding Nicolau syndrome are imperative while planning any parenteral drug injection or intralesional sclerotherapy to avoid litigation.","PeriodicalId":174870,"journal":{"name":"Journal of Skin and Stem Cell","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Skin and Stem Cell","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/JSSC.107198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction: Nicolau syndrome is an iatrogenic dreaded adverse skin reaction leading to ischemic necrosis of skin and underlying tissue after parenteral drug injection. The etiopathogenesis is poorly understood. However, inflammation, reflex vasospasm, and thrombo-embolic occlusion of blood vessels, including arterioles and arteries, are suggested as the cause of ischemia. Case Presentation: We report a 12-year-old girl who developed Nicolau syndrome after a simple office procedure of intralesional sclera therapy with sodium tetradecyl sulfate for a apyogenic granuloma on her right index finger. Three days later, she reported complaints of excruciatingly painful swelling with bluish discoloration of the right hand involving the palm, entire index, middle, and ring fingers, and distal part of the little finger. Nicolau syndrome was documented after intramuscular injections of drugs. Nevertheless, there are very few reports of Nicolau syndrome following post intralesional sclerotherapy. Conclusions: Sclerotherapy is a simple office procedure routinely performed by health care professionals (e.g., dermatologists and surgeons), and awareness about its dreaded entity is key. Stringent precautions and prompt management can prevent unfavorable complications. Additionally, prudent patient selection and detailed counseling with explicit informed consent regarding Nicolau syndrome are imperative while planning any parenteral drug injection or intralesional sclerotherapy to avoid litigation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
斑块内硬化治疗后的Nicolau综合征:一种简单手术的可怕并发症
简介:Nicolau综合征是一种医源性可怕的皮肤不良反应,在静脉注射药物后导致皮肤和皮下组织缺血性坏死。其发病机制尚不清楚。然而,炎症、反射性血管痉挛和血栓栓塞栓塞血管,包括小动脉和动脉,被认为是缺血的原因。病例介绍:我们报告了一个12岁的女孩,她在用十四烷基硫酸钠治疗她右手食指的无源性肉芽肿后,在简单的办公室手术中出现了尼科劳综合征。三天后,患者报告称右手手掌、整个食指、中指和无名指以及小指远端出现极痛的肿胀并伴有蓝色变色。肌内注射药物后出现Nicolau综合征。然而,很少有关于病灶内硬化治疗后出现Nicolau综合征的报道。结论:硬化疗法是一个简单的办公室程序,通常由卫生保健专业人员(如皮肤科医生和外科医生)执行,对其可怕实体的认识是关键。严格的预防措施和及时的治疗可以预防不良并发症。此外,在计划任何肠外药物注射或局内硬化治疗时,谨慎的患者选择和明确知情同意的详细咨询对于Nicolau综合征是必不可少的,以避免诉讼。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Crisaborole in Atopic Dermatitis An Update on the Etiopathogenesis and Management of Morbihan Disease: A Narrative Review Facial Acne Management and Sebum Reduction via Botulinum Toxin Type A Treatment: A Review The Gender-Specific Dynamics of Charismaphobia in Relation to Body-Esteem and Self-Esteem: Implications for Cosmetic and Psycho-Dermatology Observational Study of the Changes in Skin Thickness Among Children with Atopic Dermatitis Treated with Topical Mometasone Furoate 0.1% Cream
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1